Based on the Bruker Corporation stock forecast from 6 analysts, the average analyst target price for Bruker Corporation is USD 75.56 over the next 12 months. Bruker Corporation’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Bruker Corporation is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Bruker Corporation’s stock price was USD 59.68. Bruker Corporation’s stock price has changed by -2.60% over the past week, -11.14% over the past month and +0.07% over the last year.
No recent analyst target price found for Bruker Corporation
No recent average analyst rating found for Bruker Corporation
Company Overview Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. Read Less
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scie...Read More
Frequently Asked Questions About Bruker Corporation (BRKR) Stock
Based on ratings from 6 analysts Bruker Corporation's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 6 buy, 1 sell and 2 hold ratings.
BRKR stock's dividend yield is 0.32%.
Our analysis grades BRKR stock's dividend yield at F. This means that BRKR stock's dividend yield is above 50% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this BRKR may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for BRKR is USD 75.56 over the next 12 months. The maximum analyst target price is USD 90 while the minimum anlayst target price is USD 46.
BRKR stock's Price/Earning ratio is 26.41.
Our analysis grades BRKR stock's Price / Earning ratio at F. This means that BRKR stock's Price/Earning ratio is above 53% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this BRKR may be a overvalued for its sector.
The last closing price of BRKR's stock was USD 59.68.
The most recent market capitalization for BRKR is USD 9.55B.
Based on targets from 6 analysts, the average taret price for BRKR is projected at USD 75.56 over the next 12 months.
This means that BRKR's stock price may go up by +26.60% over the next 12 months.
We can't find any ETFs which contains Bruker Corporation's stock.
As per our most recent records Bruker Corporation has 9,707 Employees.
Bruker Corporation's registered address is 40 Manning Road, Billerica, MA, United States, 01821.
You can get more information about it from Bruker Corporation's website at https://www.bruker.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Bruker Corporation (BRKR) Stock
Based on ratings from 6 analysts Bruker Corporation's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 6 buy, 1 sell and 2 hold ratings.
BRKR stock's dividend yield is 0.32%.
Our analysis grades BRKR stock's dividend yield at F. This means that BRKR stock's dividend yield is above 50% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this BRKR may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for BRKR is USD 75.56 over the next 12 months. The maximum analyst target price is USD 90 while the minimum anlayst target price is USD 46.
BRKR stock's Price/Earning ratio is 26.41.
Our analysis grades BRKR stock's Price / Earning ratio at F. This means that BRKR stock's Price/Earning ratio is above 53% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this BRKR may be a overvalued for its sector.
The last closing price of BRKR's stock was USD 59.68.
The most recent market capitalization for BRKR is USD 9.55B.
Based on targets from 6 analysts, the average taret price for BRKR is projected at USD 75.56 over the next 12 months.
This means that BRKR's stock price may go up by +26.60% over the next 12 months.
We can't find any ETFs which contains Bruker Corporation's stock.
As per our most recent records Bruker Corporation has 9,707 Employees.
Bruker Corporation's registered address is 40 Manning Road, Billerica, MA, United States, 01821.
You can get more information about it from Bruker Corporation's website at https://www.bruker.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BRKR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
